COVID-19: Patients improve after immune-suppressant treatment

COVID-19: Patients improve after immune-suppressant treatment

Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving an FDA-approved drug normally given for rheumatoid arthritis, according to an observational study. Outcomes for patients who received the drug, tocilizuma…

Read More…

You May Also Like